Halberd Corporation (OTCMKTS:HALB) Stock To Watch: Company Creates Subsidiary to Apply Its Patented Technology to Treat Cancer

June 21, 2022

Halberd Corporation (OTCMKTS:HALB) has been one of the healthcare companies which has been publishing its research work related to its patented extracorporeal treatment methodology in recent times and has made considerable progress. The company has demonstrated that the process could be deployed to combat a wide range of medical conditions and this morning Halberd made another significant announcement that investors could take a look into. The company announced this morning…


Halberd Corporation (OTCMKTS:HALB) stock In Focus After Company’s CEO Letter

April 25, 2022

When the Chief Executive Officer of a company issues a letter to the shareholders then there is a lot of vital information that can be gleaned by investors. This morning the Halberd Corporation (OTCMKTS:HALB) stock could come into considerable focus among investors after its Chief Executive Officer William A Hartman issued a letter addressed to the shareholders. In light of this event, it may be a good idea for investors…


Halberd Corporation (OTCMKTS:HALB) Eliminates Protein Linked to Depression

April 7, 2022

Over the course of the past months, Halberd Corporation (OTCMKTS:HALB) has done a lot of work with regard to its research initiatives and due to the success that the company eventually found in that work, it has expanded the scope of the research. Earlier on in the week, the company made another announcement with regards to the work that they had been doing regarding the elimination of C-Reactive protein from…


Halberd Corporation (OTCMKTS:HALB) Stock In Focus: Infectious Disease Specialist Will Guide Halberd’s Extracorporeal Elimination of Disease Antigens in Animals and Then Humans

March 18, 2022

Those who are currently looking into opportunities in the healthcare sector could do well to consider having a look at the Halberd Corporation (OTCMKTS:HALB) stock.     While it is true that there has been no news about the company this morning, it was in fact in the news back on Wednesday and it is something that is worth looking into. The company announced that it was moving into the next…


Halberd Corporation (OTCMKTS:HALB) Stock Breakout Alert On Impressive Superior COVID-19 Antibody

March 2, 2022

Strong trading volume can often be an indicator of the level of activity in stock and more often than not it is a good thing. On Tuesday, it was the Halberd Corporation (OTCMKTS:HALB) stock that had emerged as a major mover on the back of the strong volume and ended the day with gains of as much as 16%. The stock soared yesterday following a key development with regards to…


Halberd Inc (OTCMKTS:HALB) Stock On Watchlist After Recent Developments

January 25, 2022

The biotech sector has always been one of the more popular sectors for investors for many years and it continues to be so. There continue to be lots of intriguing options in the sector that investors could consider looking into and one of those at this point is Halberd Inc (OTCMKTS:HALB). It is regarded as an innovative biotech company and is involved in developing treatment by virtue of the provisional…


Scientific Collaboration and Reseller Agreement Signed by GTX and Halberd (OTCMKTS:HALB)

October 13, 2021

Halberd Corporation and GTX Corp (OTCMKTS:HALB) are coming together to work on several neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, PTSD/CTE (Chronic Traumatic Encephalopathy)/ Traumatic Brain Injury), among others. Seniors, active duty and veteran soldiers, participants in contact sports and millions of people in general, are susceptible to these diseases, but there is finally some promising news. Both companies plan to combine their technology and expertise in the field…


Halberd Corp (OTCMKTS:HALB) Stock Makes a Bullish Move After The News

August 31, 2021

Publicly traded company on the OTC Market Halberd Corp (OTCMKTS:HALB) on August 30, 2021, gave an update on the Alzheimer’s Disease eradication experimentation. The experimentation is being conducted at Youngstown State University as well as Arizona State University. The company did two rounds on Phosphorylated Tau and its results were astonishing ensuring that researchers are looking to do more tests before publishing in scientific journals. Halberd confirmed that bodily fluids…